FDA Finalizes ‘Biological Product’ Definition Ahead of BPCIA Transition

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Feb 20, 2020 at 11:52 PM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,973
    Likes Received:
    3
    via A month before the long-anticipated transition of applications for certain biological products, including insulin and human growth hormone, to be deemed to be licensed as biologics, the US Food and Drug Administration (FDA) on Thursday issued a final rule amending its definition of “biological product.”

    article source